Symbravo: What Patients Need to Know

Symbravo is a prescription medicine used to treat a migraine attack in adults, with or without aura. It combines meloxicam, a nonsteroidal anti-inflammatory drug (NSAID), and rizatriptan, a triptan medicine that acts on migraine-related nerve pathways and blood vessels.

What Is Symbravo?

Symbravo is a prescription medicine for the acute treatment of migraine attacks in adults, including migraine with or without aura. It is designed to be taken when a migraine begins or is already underway; it is not a daily preventive medicine and is not intended to stop future migraines from occurring.

Symbravo contains meloxicam and rizatriptan. Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that helps reduce pain and inflammation. Rizatriptan belongs to a group of medicines called triptans, which target migraine-related pathways involving serotonin receptors. The fixed-dose combination is intended to address more than one part of a migraine attack.

Migraine is more than a routine headache. It can cause throbbing head pain, nausea, sensitivity to light or sound, and difficulty functioning. Some people experience aura, such as temporary visual changes, tingling, or language symptoms, before or during an attack. A clinician can help confirm whether symptoms fit migraine and whether Symbravo is an appropriate option.

How Symbravo Works and What to Expect

During a migraine attack, changes occur in pain-sensitive nerves and blood vessels around the brain. Rizatriptan works by activating selected serotonin receptors that are involved in migraine pain signaling. Meloxicam reduces the production of substances called prostaglandins, which contribute to inflammation and pain. Together, these actions may help relieve migraine symptoms in appropriately selected adults.

Symbravo is used for an acute migraine attack rather than for emergency treatment of a suspected stroke or another serious neurological condition. It has not been established as a treatment for certain uncommon headache disorders, such as hemiplegic migraine or basilar-type migraine. A sudden, severe, or unfamiliar headache should be assessed rather than automatically treated as a person’s usual migraine.

Response can differ from person to person. Some people notice improvement in head pain and associated symptoms, while others may need a different acute or preventive migraine approach. Keeping a headache diary can help a clinician assess attack frequency, likely triggers, response to treatment, and possible medication overuse.

Who May Be Considered for Symbravo?

A healthcare professional may consider Symbravo for an adult whose migraine diagnosis is established and who needs treatment for attacks as they occur. The decision should take into account the person’s migraine pattern, previous response to treatments, other health conditions, and current medicines. Regulatory approval and availability can vary between countries.

Before prescribing it, clinicians commonly ask about heart disease, stroke or transient ischemic attack, circulation problems, high blood pressure, stomach ulcers or bleeding, kidney disease, liver disease, asthma, and medicine allergies. These details matter because both NSAIDs and triptans can pose important risks in particular situations.

People with frequent migraines may benefit from a broader care plan. This can include identifying triggers, improving sleep regularity, considering preventive treatment when appropriate, and reviewing whether attacks may be linked to another headache condition. A specialist assessment can be especially useful when migraine symptoms are disabling, changing, or difficult to control.

Important Safety Considerations

Symbravo is not suitable for everyone. Because it contains rizatriptan, it is generally not used by people with certain forms of coronary artery disease, prior stroke or transient ischemic attack, peripheral vascular disease, or uncontrolled high blood pressure. It may also be unsuitable for people who have certain types of migraine involving weakness or brainstem symptoms. A clinician may need to evaluate cardiovascular risk before prescribing a triptan, particularly for people with multiple risk factors.

Meloxicam and other NSAIDs can increase the risk of serious cardiovascular events, stomach or intestinal bleeding, ulcers, kidney problems, liver problems, and severe allergic or skin reactions. The risk of gastrointestinal bleeding can be higher in older adults and in people who have had ulcers or bleeding before, drink substantial amounts of alcohol, or use medicines such as anticoagulants, corticosteroids, or some antidepressants.

Symbravo should not be combined with certain other migraine medicines or interacting drugs without medical guidance. In particular, taking another triptan or an ergot-containing migraine medicine too close together may be unsafe. Rizatriptan may also interact with medicines that affect serotonin, and meloxicam can interact with medicines including blood thinners, some blood pressure medicines, diuretics, lithium, and methotrexate. A pharmacist or prescriber should review all prescription medicines, over-the-counter products, supplements, and herbal remedies.

It is important to use Symbravo exactly as prescribed. Using treatments for acute headache too frequently can lead to medication-overuse headache, in which headaches become more frequent or harder to treat. A person who regularly needs acute migraine medicine should discuss the pattern with a qualified clinician rather than increasing use independently.

Possible Side Effects

Side effects can occur with any medicine, although not everyone experiences them. Potential effects related to rizatriptan can include dizziness, sleepiness, tiredness, nausea, tingling, or feelings of pressure or tightness. These symptoms are often temporary, but chest, throat, neck, or jaw discomfort should be taken seriously, especially if it is severe, persistent, or accompanied by shortness of breath or sweating.

Possible effects related to meloxicam include indigestion, nausea, abdominal discomfort, diarrhea, constipation, headache, dizziness, and fluid retention. NSAIDs can occasionally cause more serious stomach or intestinal bleeding. Warning signs include black or tar-like stools, blood in vomit, persistent stomach pain, fainting, or unusual weakness.

Urgent medical assessment is also needed for signs of a serious allergic reaction, such as facial swelling, trouble breathing, widespread rash, blistering, or peeling skin. Symptoms of serotonin syndrome are uncommon but may include agitation, confusion, fever, sweating, fast heartbeat, muscle stiffness, tremor, or diarrhea, particularly when serotonergic medicines are used together. A clinician should be contacted promptly if new or concerning symptoms develop.

Using Symbravo Safely as Part of Migraine Care

Symbravo should be taken according to the prescribing instructions provided by the treating clinician and pharmacist. It should not be shared with another person, even if their headaches seem similar. Patients should not take extra doses, combine it with another triptan, or add an NSAID-containing pain reliever unless a healthcare professional has confirmed that doing so is appropriate.

For some people, a calm, dark environment, hydration, rest, regular meals, and early treatment of a familiar migraine attack can be helpful alongside prescribed care. These measures do not replace medical treatment, but they can support comfort during an episode. Identifying patterns related to sleep disruption, stress, skipped meals, alcohol, hormonal changes, or sensory triggers may also help with migraine management.

People who are pregnant, trying to become pregnant, or breastfeeding should discuss migraine treatment with their obstetric or healthcare team. NSAIDs may carry particular concerns during pregnancy, especially later in pregnancy. Anyone planning surgery should also tell their care team about all medicines they use, including Symbravo.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals can assess migraine symptoms and discuss appropriate diagnostic and treatment options for international patients.

When to Seek Medical Care

Emergency medical care is needed for a sudden, extremely severe headache that reaches maximum intensity quickly, particularly if it is unlike previous headaches. Immediate assessment is also important for headache with fainting, seizure, fever and stiff neck, confusion, new weakness or numbness, difficulty speaking, vision loss, severe dizziness, or loss of balance. These symptoms can have causes other than migraine and should not be self-treated as a typical attack.

A person should contact a clinician promptly if migraines become more frequent, change in character, regularly wake them from sleep, occur after a head injury, or do not respond to their usual treatment. Medical advice is also appropriate if acute migraine medicine is needed often, as this may signal a need to review the diagnosis or consider preventive care.

Anyone using Symbravo should seek urgent help for symptoms of a heart problem, serious allergic reaction, gastrointestinal bleeding, severe abdominal pain, marked reduction in urine output, or a severe skin reaction. Timely review supports safer treatment and helps ensure that new symptoms are not overlooked.

Frequently asked questions

Is Symbravo a migraine prevention medicine?

No. Symbravo is intended for the acute treatment of a migraine attack in adults. It is not designed to prevent migraine attacks or to be taken routinely every day.

What medicines are in Symbravo?

Symbravo combines meloxicam and rizatriptan. Meloxicam is an NSAID pain and anti-inflammatory medicine, while rizatriptan is a triptan that acts on pathways involved in migraine attacks.

Can Symbravo be taken with other migraine medicines?

Some combinations may be unsafe, particularly other triptans or ergot-containing medicines taken close together. A prescriber or pharmacist should review all migraine medicines, pain relievers, antidepressants, and supplements before Symbravo is used.

Who should not take Symbravo?

People with certain heart or blood vessel conditions, prior stroke, uncontrolled high blood pressure, serious NSAID allergy, or a history of some gastrointestinal problems may not be suitable candidates. The prescribing clinician should assess individual medical history and medicine interactions.

Can Symbravo cause medication-overuse headache?

Frequent use of medicines intended to stop headaches can contribute to medication-overuse headache in some people. Anyone needing acute migraine treatment regularly should discuss this with a clinician, who can review treatment use and consider preventive strategies if needed.

What should someone do if a headache feels different from usual?

A sudden, severe, or unfamiliar headache should be medically assessed rather than assumed to be migraine. Emergency care is especially important if the headache occurs with weakness, speech difficulty, confusion, fainting, fever and stiff neck, or vision loss.

References

• U.S. Food and Drug Administration
• National Institute of Neurological Disorders and Stroke
• American Migraine Foundation
• Mayo Clinic
• National Library of Medicine

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.